Lv01
0 积分 2023-11-27 加入
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects
33分钟前
已完结
Major histocompatibility complex (MHC) class I and class II proteins: impact of polymorphism on antigen presentation
2小时前
已完结
mRNA Cancer Vaccines: Construction and Boosting Strategies
14天前
已完结
Cancer mRNA vaccines: clinical advances and future opportunities
14天前
已完结
Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids
4个月前
已完结
Dendritic cells as cancer therapeutics
5个月前
已完结
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
5个月前
已完结
Transforming the understanding of brain immunity
5个月前
已完结
Designing drug delivery systems for cell therapy
5个月前
已完结
Resistance to Immune Checkpoint Blockade: IFNγ or MHC-I?
9个月前
已完结
皖公网安备34019202002308
